Three studies evaluated the rate of CHFR promoter methylation in NSCLC and normal lung tissue, pooled OR suggested CHFR promoter methylation in NSCLC was ten times higher than in normal lung tissue. The gene discussed is CHFR; the disease is non-small cell lung carcinoma.